Helga Mikkelsen

Helga Mikkelsen is an accomplished investment manager with extensive experience in the life sciences sector. Since May 2018, Helga has served as an Investment Manager at Brandon Capital, where responsibilities include supporting life science companies from proof-of-concept to commercialization. Additional roles include Investment Analyst at Cancer Research Trust and Director positions at Azura Ophthalmics Limited and OncoRes Medical. Helga's expertise is further demonstrated through board observer roles at StartupWA and Perth Biodesign, and advisory council membership at Respirion Pharmaceuticals. Academic credentials include a PhD in Microbiology from the University of Cambridge, an MSc in Biotechnology, and a BSc in Chemical Engineering from DTU.